Even though 10 times as many other vaccine products have been given out since 1991 as compared to the total of 673 million COVID shots given out up to Mar 2023, COVID shots lead the pack with regard to many adverse event reports. They don’t just lead the pack, but are often ahead by an order of magnitude or more.
Medical historians of the future will have to explain how it could have been that, while a product was leading to an order of magnitude more adverse events on so many fronts, how it could have been that regulatory officials were so slow in acknowledging the unprecedented disparity in risk.
Here are the reports since 1991 that have been submitted to VAERS for “Heavy menstrual bleeding”:
That’s 42 reports in total over the course of 32.25 years of reporting — less than 2 total reports per year. Astute readers may, at this point, note that there seems to be a product that is missing from the “Vaccine type” column in the table above. And that’s because I deliberately left one product out in order to show a contrast.
Here is the full report, including that “missing” product:
While the normal reporting rate for heavy menstrual bleeding had averaged under 2 reports per year for 32 years in a row, after the COVID shots were made available, the reporting rate increased by more than 300-fold. While under 20 total reports for HPV vaccine had been logged in 32 years of VAERS, over 5,000 got logged for COVID shots.
In a fraction of the exposure time, COVID shots were able to lead to 314 times as many reports as HPV vaccines, the next highest reporting rate.